Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 12, 2007
Diabetes 56:1324-1332, 2007
DOI: 10.2337/db06-1579
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1579v1
56/5/1324    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, C.-Y.
Right arrow Articles by Butler, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, C.-Y.
Right arrow Articles by Butler, P. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced ß-Cell Apoptosis in h-IAPP Transgenic Mice

Chia-Yu Lin1, Tatyana Gurlo1, Rakez Kayed2, Alexandra E. Butler1, Leena Haataja1, Charles G. Glabe2, and Peter C. Butler1

1 Larry Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
2 Department of Molecular Biology and Biochemistry, University of California, Irvine, California

Address correspondence and reprint requests to Dr. Peter C. Butler, Larry Hillblom Islet Research Center, UCLA David Geffen School of Medicine, 900A Weyburn Place North, Los Angeles, CA 90095-7345. E-mail: pbutler{at}mednet.ucla.edu

Abbreviations: AßP, Alzheimer's ß protein; h-IAPP, human islet amyloid polypeptide; ELISA, enzyme-linked immunosorbent assay; IAPP, islet amyloid polypeptide; r-IAPP, rodent islet amyloid polypeptide; TBS, Tris-buffered saline

OBJECTIVE—Islets in type 2 diabetes are characterized by a deficit in ß-cells, increased ß-cell apoptosis, and islet amyloid derived from islet amyloid polypeptide (IAPP). The toxic form of amyloidogenic protein oligomers are distinct and smaller than amyloid fibrils and act by disrupting membranes. Using antibodies that bind to toxic IAPP oligomers (but not IAPP monomers or fibrils) and a vaccination-based approach, we sought to establish whether IAPP toxic oligomers form intra- or extracellularly and whether vaccination to induce anti-toxic oligomer antibodies prevents IAPP-induced apoptosis in human IAPP (h-IAPP) transgenic mice.

RESEARCH DESIGN AND METHODS—Pancreas was sampled from two h-IAPP transgenic mouse models and examined by immunohistochemistry for toxic oligomers. The same murine models were vaccinated with toxic oligomers of Alzheimer ß protein (AßP1–40) and anti-oligomer titers, and blood glucose and islet pathology were monitored.

RESULTS—Toxic oligomers were detected intracellularly in ~20–40% of h-IAPP transgenic ß-cells. Vaccine induced high titers of anti–h-IAPP toxic oligomers in both transgenic models, but ß-cell apoptosis was, if anything, further increased in vaccinated mice, so that neither loss of ß-cell mass nor diabetes onset was delayed.

CONCLUSIONS—IAPP toxic oligomers form in h-IAPP transgenic mouse models, and anti-toxic oligomer antibodies do not prevent h-IAPP–induced ß-cell apoptosis. These data suggest that prevention of h-IAPP oligomer formation may be more useful than a vaccination-based approach in the prevention of type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Zhang, H. Liu, H. Yu, and G. J.S. Cooper
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet {beta}-Cells
Diabetes, February 1, 2008; 57(2): 348 - 356.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-j. Huang, C.-y. Lin, L. Haataja, T. Gurlo, A. E. Butler, R. A. Rizza, and P. C. Butler
High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress Mediated {beta}-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes
Diabetes, August 1, 2007; 56(8): 2016 - 2027.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.